Search Results 841-850 of 16383 for pharmacogenetics
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Early detection of recurrent prostate cancer is crucial for patients beating the disease a second time. The work of a team of Mayo Clinic physicians and ...
This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients. Participation ...
The purpose of this study is to test the effectiveness and safety of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...
The primary objectives for this study are to compare each investigational arm versus standard of care (SOC) for superiority in overall survival in 1st and/or ...
Latest stories · Preeclampsia linked to increased markers of brain cell damage, inflammation featured image · Expert Alert: Options for laryngeal regeneration ...
This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...
About this study. The aim is the characterization of the microbiome of subjects experiencing benign reproductive tract disorders and its comparison to the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.